Abacavir safety and effectiveness in young infants with HIV in South African observational cohorts

Abacavir safety and effectiveness in young infants with HIV in South African observational cohorts

Background WHO guidelines recommend abacavir in first-line antiretroviral treatment for children and neonates. However, there is no approved dose

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Antiviral therapy 2023-04, Vol.28 (2)
Hauptverfasser: de Waal, Reneé, Rabie, Helena, Technau, Karl-Günter, Eley, Brian, Sipambo, Nosisa, Cotton, Mark, Boulle, Andrew, Wood, Robin, Tanser, Frank, Fatti, Geoffrey, Egger, Matthias, Davies, Mary-Ann
Format: Artikel
Sprache:eng
Schlagworte:
Abacavir
Age
Antiretroviral therapy
CD4 antigen
Confidence intervals
HIV
Human immunodeficiency virus
Infants
Neonates
Zidovudine
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background WHO guidelines recommend abacavir in first-line antiretroviral treatment for children and neonates. However, there is no approved dose
ISSN:1359-6535
2040-2058
DOI:10.1177/13596535231168